We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Heterologous (“Nonspecific”) and Sex-Differential Effects of Vaccines: Epidemiology, Clinical Trials, and Emerging Immunologic Mechanisms.
- Authors
Flanagan, K. L.; van Crevel, R.; Curtis, N.; Shann, F.; Levy, O.
- Abstract
Vaccines can have profound effects on susceptibility to infections that are unrelated to stimulation of vaccine-specific immunity. An international group of experts attended the second Optimmunize meeting in 2012 to discuss advances in understanding the mechanisms underlying these heterologous effects.A growing body of evidence from epidemiologic, clinical, and immunologic studies indicates that vaccines can influence morbidity and mortality independent of vaccine-specific B-cell or T-cell immunity. For example, the live attenuated measles vaccine and BCG vaccine may reduce mortality from infections other than measles or tuberculosis, respectively. Immunologists call these heterologous effects and epidemiologists have called them nonspecific effects, indicating that they manifest against a broad range of pathogens/disease. These effects differ by sex, can be beneficial or detrimental, and appear to be mediated by mechanisms including innate immune memory (also known as “trained immunity”) and cross-reacting lymphocytes. Herein we review recent studies in this emerging field based on a meeting of experts, the recent Optimmunize meeting, held in Copenhagen, Denmark, in August 2012. Further characterization of these effects is likely to expand the way vaccines are evaluated and alter the manner and sequence in which they are given.
- Subjects
EPIDEMIOLOGY; SEX differences (Biology); VACCINES; CLINICAL trials; CELLULAR immunity; DISEASE susceptibility
- Publication
Clinical Infectious Diseases, 2013, Vol 57, Issue 2, p283
- ISSN
1058-4838
- Publication type
Article